Prolong Pharmaceuticals Competitors and Similar CompaniesClear all

Prolong Pharmaceuticals's competitors and similar companies include Jiangsu Hansoh Pharmaceutical Group, Takeda, PLIVA and Biocon.
Prolong Pharmaceuticals
Prolong Pharmaceuticals
Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia.
Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.
Takeda
Takeda
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
PLIVA
PLIVA
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
Biocon
Biocon
Biocon is a company that develops and manufactures biopharmaceutical products.
Founding Date
Founding Date
2005
Founding Date
1995
Founding Date
1781
Founding Date
1921
Founding Date
1978
Type
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
South Plainfield, US HQ
Locations
Lianyungang Shi, CN HQ
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Zagreb, HR HQ
Sarajevo, BA
Skopje, MK
Belgrade, RS
Locations
Bengaluru, IN HQ
Bengaluru, IN
Nanakramguda, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
Delémont, CH
see more
Employees
Employees
225% increase
Employees
8,989
Employees
47,4554% decrease
Employees
1,685
Employees
16,5612% increase

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥15b (FY, 2025)
Revenue (est.)
¥4.6t (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
₹167.8b (FY, 2026)
Cost of goods
Cost of goods
N/A
Cost of goods
¥1.1b (FY, 2025)
Cost of goods
¥818.8b (FY, 2025)
Cost of goods
N/A
Cost of goods
₹56.9b (FY, 2026)
Gross profit
Gross profit
N/A
Gross profit
¥14b (FY, 2025)
Gross profit
¥3.8t (FY, 2025)
Gross profit
N/A
Gross profit
₹115.8b (FY, 2026)
Net income
Net income
N/A
Net income
¥5.6b (FY, 2025)
Net income
¥108.1b (FY, 2025)
Net income
N/A
Net income
₹3.7b (FY, 2026)

Funding

Total funding raised
Total funding raised
$ 30m
Total funding raised
N/A
Total funding raised
$ 57.8m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Jiangsu Hansoh Pharmaceutical Group
HQ
Lianyungang Shi, CN
Employees
8,989

Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.

View company
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease

Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.

View company
PLIVA
HQ
Zagreb, HR

PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.

View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase

Biocon is a company that develops and manufactures biopharmaceutical products.

View company